and short life expectancy with standard treatment. Reported here is a patient with an intermediate-grade NHL who presented with extensive BMN and fibrosis. Surprisingly, A patient with malignant lymphoma, large cell type and extensive bone marrow necrosis at presentation is progenitor cells were mobilized and collected from the circulation after high doses of chemotherapy with growth facreported. Bone marrow necrosis persisted even after a complete remission was induced with standard chemotor support, and reinfused successfully as part of a subsequent autologous peripheral blood progenitor cell therapy. Because of this adverse prognostic factor, circulating stem cells were collected and reinfused followtransplant (PBPCT) following a myeloablative chemotherapeutic regimen. ing a myeloablative regimen consisting of busulfan, etoposide and cyclophosphamide. The patient engrafted rapidly and a subsequent bone marrow examination Case report was free of both lymphoma and necrosis. To the best of our knowledge, this is the first reported patient with A 38-year-old man presented with several weeks of fever, chills and low backache. There was no history of weight extensive bone marrow necrosis in whom circulating progenitor cells were harvested and utilized successloss or night sweats. Physical examination revealed a pyrexia of 39°C and tenderness across the lumbar spine. fully.
A radionuclide scintiscan of the skeletal system demona further indicator of the poor prognosis associated with its strated increased uptake in the third lumbar vertebra. Magdiagnosis. It has also been suggested that the greater the netic resonance imaging (MRI) of the spine revealed a difdegree of BMN, the worse the clinical outcome.
2 Patients fuse marrow signal abnormality on both T1 and T2-with BMN and an underlying malignancy rarely survive weighted images suggesting a myelophthisic process. The longer than a year, and most die within a few weeks of bone marrow was inaspirable. Bilateral posterior iliac crest diagnosis.
1 In two pathologic series of 368 and 270 bone bone marrow biopsies revealed a lymphocytic infiltrate, and marrow biopsy specimens, respectively, the incidence of extensive areas of frank necrosis (Figure 1 ). Diffuse reticusevere BMN was only 3-6.8%. 5, 6 The combined incidence lin fibrosis was also noted. The morphologic findings were of any degree of BMN in 52 patients with non-Hodgkin's consistent with malignant lymphoma, large cell type, and lymphoma (NHL) in these studies was 61.5%. 5, 6 However, immunophenotyping established the presence of a B cell the incidence of severe BMN in these 52 individuals was lymphoma. Radiologic studies of the chest, abdomen and only 13.5%. 5, 6 The clinical outcome of these patients was pelvis failed to visualize any pathologic lymphadenopathy. not further elaborated upon in either of the studies. MoreChemotherapy consisting of cyclophosphamide 750 mg/m 2 , over, only two out of 29 patients with NHL reported in the doxorubicin 50 mg/m 2 and vincristine 1.4 mg/m 2 all given first series were noted to have severe BMN prior to the intravenously on day 1, and prednisone 100 mg/m 2 orally administration of chemotherapy. 5 The use of aggressive prion days 1-5 was repeated every 3 weeks. A total of six mary treatment such as high-dose chemotherapy should be cycles of this regimen was administered. A subsequent considered in such patients because of their poor outcome bone marrow biopsy demonstrated persistent areas of necrosis admixed with normal hematopoietic elements. The patient was referred to our facility for an autologous The pathogenesis of bone marrow necrosis is poorly understood 7,8 and often overlooked. Underlying malignant disof 7.1 × 10 6 CD34-positive cells/kg body weight was collected from the circulation. The number of colony-forming orders include acute and chronic leukemias, Hodgkin's disease, NHL and solid tumors. A system for grading the units granulocyte-macrophage (CFU-GM) obtained after 14 days of culture of these cells was 158 colonies/10 5 cells. severity of BMN has been established previously. 6 Severe necrosis (grade III) is defined as a large focus or foci of Bilateral bone marrow biopsies obtained after these two cycles of chemotherapy still contained areas of necrosis and necrosis occupying greater than 50% of the bone marrow biopsy specimen. The most common clinical features fibrosis but without evidence of lymphoma.
The patient received a myeloablative conditioning include bone pain and tenderness, fever, elevated serum levels of LDH and alkaline phosphatase, and a leukoregimen of busulfan 16 mg/kg body weight orally, etoposide 60 mg/kg body weight intravenously, and cyclophoserythroblastic blood picture.
1,3
Although the incidence of severe BMN in association phamide 90 mg/kg body weight intravenously. Autologous progenitor cells were infused on day 0. The patient with NHL in small pathologic studies is 13.5%, 5, 6 clinical descriptions of such cases have been sparsely reported in remained neutropenic from day +4 to day +8 following the infusion of progenitor cells. Dependence on platelet transthe literature. It is quite possible that many cases of severe BMN are missed in patients with NHL, perhaps impacting fusions ended on day +10. A bone marrow biopsy obtained 3 months after the PBPCT demonstrated 50% cellularity adversely on their eventual outcome. In a recent review of the literature, only 17 cases of NHL and co-existent BMN with trilinear maturation (Figure 2 ). There was no evidence could be identified in the antemortem setting.
2 Most of References these patients died within a few weeks of the diagnosis of BMN. Only two of these reported patients survived longer
